Results
Cohance Lifesciences Board Meeting for Q2 FY27 Results
Cohance Lifesciences board meeting scheduled for 6 November 2026 to approve unaudited Q2 and H1 FY27 financial results.
Trading window closure for designated persons extended until 9 November 2026 as
